Phase II Double-Blind, Placebo-Controlled Study of the Reinforcing Effects of Alprazolam in Patients With Anxiety

NCT00004373 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

NIH

Sponsor class

Conditions

Anxiety Disorder
Panic Disorder

Interventions

DRUG: alprazolam

Sponsor

National Institute on Drug Abuse (NIDA)

Collaborators

[object Object]